Tatiana Ferreira de Almeida

Tatiana Ferreira de Almeida

Auto-generated profile, based on publicly available information

Tatiana Ferreira de Almeida

Hospital Israelita Albert Einstein

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2024 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
RBRodrigo A.S. Barreiro
Rodrigo A.S. Barreiro
TATatiana F. de Almeida
Tatiana F. de Almeida
CGCatarina Gomes
Catarina Gomes
FMFrederico Monfardini
Frederico Monfardini
AFAllysson A. de Farias
Allysson A. de Farias
MNMichel S. Naslavsky
Michel S. Naslavsky

16 November 2023 in Human Genomics
Verified
Journal Article
Open access
PDF file
CQCaio Robledo Quaio
Caio Robledo Quaio
JCJosé Ricardo Magliocco Ceroni
José Ricardo Magliocco Ceroni
MPMichele Araújo Pereira
Michele Araújo Pereira
ATAnne Caroline Barbosa Teixeira
Anne Caroline Barbosa Teixeira
RYRenata Yoshiko Yamada
Renata Yoshiko Yamada
JFJoao Bosco de Oliveira Filho
Joao Bosco de Oliveira Filho
Background: Next-generation sequencing has had a significant impact on genetic disease diagnosis, but the interpretation of the vast amount of genomic data it generates can be challenging. To address this, the American College of Medical Genetics and Genomics and the Association for Molecular Pathology have established guidelines for standardized variant interpretation. In this manuscript, we present the updated Hospital Israelita Albert Einstein Standards for Constitutional Sequence Variants Classification, incorporating modifications from leading genetics societies and the ClinGen initiative. Results: First, we standardized the scientific publications, documents, and other reliable sources for this document to ensure an evidence-based approach. Next, we defined the databases that would provide variant information for the classification process, established the terminology for molecular findings, set standards for disease-gene associations, and determined the nomenclature for classification criteria. Subsequently, we defined the general rules for variant classification and the Bayesian statistical reasoning principles to enhance this process. We also defined bioinformatics standards for automated classification. Our workgroup adhered to gene-specific rules and workflows curated by the ClinGen Variant Curation Expert Panels whenever available. Additionally, a distinct set of specifications for criteria modulation was created for cancer genes, recognizing their unique characteristics. Conclusions: The development of an internal consensus and standards for constitutional sequence variant classification, specifically adapted to the Brazilian population, further contributes to the continuous refinement of variant classification practices. The aim of these efforts from the workgroup is to enhance the reliability and uniformity of variant classification.


27 April 2025 in medRxiv
Verified
Preprint
Open access
PDF file
ACAntonio Victor Campos Coelho
Antonio Victor Campos Coelho
RARafael Sales de Albuquerque
Rafael Sales de Albuquerque
CGCatarina dos Santos Gomes
Catarina dos Santos Gomes
JJJose Bandeira Do Nascimento Junior
Jose Bandeira Do Nascimento Junior
GOGustavo Santos de Oliveira
Gustavo Santos de Oliveira
TCThe Brazilian Rare Genomes Project Consortium
The Brazilian Rare Genomes Project Consortium
Background: Whole-Genome Sequencing (WGS) and Whole-Transcriptome Sequencing (WTS) have emerged as transformative tools in the diagnosis of rare diseases with complex phenotypes. These technologies enable deep analysis of the genome and RNA expression, uncovering structural, intronic, non-coding, and mitochondrial variants that traditional methods might miss, thus facilitating the understanding of gene function and regulation. Methods: We enrolled 8966 patients with suspected rare diseases or hereditary cancer risk syndromes from 21 centers throughout Brazil. Their genomes were sequenced with short, paired-end reads, and diagnostic reports were provided for 7614 of these patients. Results: The overall diagnostic yield was 35.8%, with an additional 5.6% of all Positive reports including gains from WGS compared to other diagnostic tests. In patients with pathogenic/likely pathogenic copy number or structural variants, WGS provided a 10.2% increase in diagnostic yield. Almost 1900 variant/phenotype interpretations were submitted to ClinVar. Conclusion: WGS and WTS are proving to be invaluable resources for shortening the diagnostic odyssey of patients with rare diseases, providing crucial genomic diagnostics, and enriching genetic databases with variant interpretations from underrepresented populations. These technologies have the potential to significantly enhance the precision of healthcare in genetically diverse populations. Key Points for NEJM Editors and Reviewers: Scope : Largest Brazilian rare disease–focused sequencing project to date. Findings : A 35.8% diagnostic yield with notable additional detection of structural, deep intronic, non-coding, and mitochondrial variants. Impact : Shortens diagnostic odyssey for patients, enriches ClinVar with almost 1900 variant interpretations from underrepresented populations, and demonstrates potential cost-effectiveness of integrating WGS into public healthcare. These interim results underscore how national WGS programs can facilitate precision medicine, especially in genetically diverse and previously underrepresented populations.

2 October 2014 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
TATatiana F. Almeida
Tatiana F. Almeida
DSDiogo C. Soares
Diogo C. Soares
CQCaio Robledo Quaio
Caio Robledo Quaio
RHRachel S. Honjo
Rachel S. Honjo
DBDébora R. Bertola
Débora R. Bertola
CKChong Ae Kim
Chong Ae Kim

17 June 2019 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
TATatiana Ferreira de Almeida
Tatiana Ferreira de Almeida